Development of a knowledgebase to enable streamlined analysis and interpretation of NGS data from pediatric leukemia cohorts
Twenty years ago, the first human genome was sequenced at a cost of 3 billion dollars. Today, this can be done in a day at a cost of approximately $1000. Despite this drastic reduction, the promise of personalized medicine, to customize therapy for each patient, has not yet been realized through next generation sequencing (NGS). While sequencing is becoming a commodity, the data analysis remains a significant challenge. Streamline Genomics addresses these challenges by providing clinicians with a powerful and user-friendly analysis platform. The goal of this project is to improve this platform to allow doctors to interact with a simple, intuitive, interface that leverages the wealth of cancer genomics information available, allowing them to rapidly access the most relevant results of their clinical genomic sequencing. TO BE CONT’D
View Full Project DescriptionFrançois Dragon
Streamline Genomics
Life Sciences
Health and Related Sciences & Technology; Professional, scientific and technical services
Université du Québec à Montréal
Accelerate